Co-Authors
This is a "connection" page, showing publications co-authored by NEETA SOMAIAH and GEORGE SIMON.
Connection Strength
2.946
-
Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung. Oncoscience. 2014; 1(8):522-528.
Score: 0.489
-
A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer. Clin Lung Cancer. 2014 Jan; 15(1):21-51.
Score: 0.466
-
A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(16 Suppl 5):S342-68.
Score: 0.435
-
Molecular targeted agents and biologic therapies for lung cancer. J Thorac Oncol. 2011 Nov; 6(11 Suppl 4):S1758-85.
Score: 0.404
-
Molecular targeted agents and biologic therapies for non-small cell lung cancer. J Thorac Oncol. 2010 Dec; 5(12 Suppl 6):S434-54.
Score: 0.379
-
Molecular targeted therapy in non-small cell lung cancer: an overview of available agents. J Thorac Oncol. 2009 Nov; 4(11 Suppl 3):S1046-56.
Score: 0.351
-
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations. Oncotarget. 2018 Apr 13; 9(28):19891-19899.
Score: 0.158
-
Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery. Cancer Control. 2014 Jan; 21(1):57-62.
Score: 0.117
-
Biomarkers with predictive and prognostic function in non-small cell lung cancer: ready for prime time? J Natl Compr Canc Netw. 2010 Jul; 8(7):822-32.
Score: 0.092
-
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol. 2015 Jan; 10(1 Suppl 1):S1-63.
Score: 0.031
-
Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010). J Thorac Oncol. 2011 Jan; 6(1):227-32.
Score: 0.024